Methylprednisolone pulse therapy for relapsing polychondritis (RP) combined with heart block: myth or reality?
Eur Rev Med Pharmacol Sci. 2022 Mar;26(6):1789. doi: 10.26355/eurrev_202203_28320.NO ABSTRACTPMID:35363323 | DOI:10.26355/eurrev_202203_28320 (Source: Pharmacological Reviews)
Source: Pharmacological Reviews - April 1, 2022 Category: Drugs & Pharmacology Authors: M Tang Q-P Xie K Zhu X-L Fu Source Type: research
Methylprednisolone pulse therapy for relapsing polychondritis (RP) combined with heart block: myth or reality?
Eur Rev Med Pharmacol Sci. 2022 Mar;26(6):1789. doi: 10.26355/eurrev_202203_28320.NO ABSTRACTPMID:35363323 | DOI:10.26355/eurrev_202203_28320 (Source: European Review for Medical and Pharmacological Sciences)
Source: European Review for Medical and Pharmacological Sciences - April 1, 2022 Category: Drugs & Pharmacology Authors: M Tang Q-P Xie K Zhu X-L Fu Source Type: research
Methylprednisolone pulse therapy for relapsing polychondritis (RP) combined with heart block: myth or reality?
Eur Rev Med Pharmacol Sci. 2022 Mar;26(6):1789. doi: 10.26355/eurrev_202203_28320.NO ABSTRACTPMID:35363323 | DOI:10.26355/eurrev_202203_28320 (Source: Pharmacological Reviews)
Source: Pharmacological Reviews - April 1, 2022 Category: Drugs & Pharmacology Authors: M Tang Q-P Xie K Zhu X-L Fu Source Type: research
Methylprednisolone pulse therapy for relapsing polychondritis (RP) combined with heart block: myth or reality?
Eur Rev Med Pharmacol Sci. 2022 Mar;26(6):1789. doi: 10.26355/eurrev_202203_28320.NO ABSTRACTPMID:35363323 | DOI:10.26355/eurrev_202203_28320 (Source: European Review for Medical and Pharmacological Sciences)
Source: European Review for Medical and Pharmacological Sciences - April 1, 2022 Category: Drugs & Pharmacology Authors: M Tang Q-P Xie K Zhu X-L Fu Source Type: research
Case Report: An Isolated Abducens Palsy Secondary to Lyme Disease
CONCLUSIONS
Lyme disease is a systemic illness that can have widely varying manifestations, including ocular findings. Eye involvement may be the only presenting symptom, allowing eye care providers to serve an important role in disease recognition and management. (Source: Optometry and Vision Science)
Source: Optometry and Vision Science - April 1, 2022 Category: Opthalmology Tags: REPORTS Source Type: research
Relapsing polychondritis after treatment with PD-1 blockade
SummaryNivolumab, a programmed death 1 blockade drug, is used in various types of cancers and can cause a unique immune-related adverse event (irAE). Relapsing polychondritis (RP) is a rare autoimmune disease that mainly involves inflammation of the auricle, nose and airway cartilage. A 72-year-old man with mandibular cancer received nivolumab after surgery for the primary lesion and radiation therapy for lung metastases. He then developed radiation pneumonitis, and prednisolone (PSL) was started. During the tapering of PSL, he developed exertional dyspnea and cough. The condition of mandibular cancer and radiation pneumon...
Source: Investigational New Drugs - April 1, 2022 Category: Drugs & Pharmacology Source Type: research
